3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Conditions
Pain, Postoperative
2
Breast Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
1
Oropharyngeal Neoplasms
1
Nevus, Pigmented
1
Neuroma
1
Neuralgia
1
Melanoma
1
Localised Prostate Cancer
1
Chronic Pain
1
Carcinoma, Squamous Cell
1
Interventions
Cisplatin
22
Magnetic Resonance Spectroscopy
15
Specimen Handling
13
Platinum
12
Radiotherapy, Intensity-Modulated
11
1,2-diaminocyclohexaneplatinum II citrate
11
Radiotherapy
10
Radiation
10
Carboplatin
9
Biopsy
5
pembrolizumab
4
Taxes
4
Surveys and Questionnaires
4
Paclitaxel
4
Nivolumab
4
Docetaxel
4
Chemoradiotherapy
4
Cetuximab
4
Fluorodeoxyglucose F18
3
(225)Ac-DOTA-c(RGDyK)
3
durvalumab
2
X-Rays
2
Standard of Care
2
Radiotherapy, Image-Guided
2
Observation
2
Interviews as Topic
2
Immunoglobulin G
2
Fluorouracil
2
Disulfides
2
toripalimab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Oropharyngeal Neoplasms
×
Lidocaine
×
90 days
×
Clear all
NCT06747390
2026-05-12
856397
Abramson Cancer Center at Penn Medicine
Phase 1
Recruiting
30 enrolled